Skip to content

Comparison of standard and tubeless intercostal percutaneous Kidney stone breaker in patients with kidney stone

Comparison of standard and tubeless intercostal percutaneous nephrolithotomy in patients with kidney stone: A single blind randomized clinical trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201706309014N172
Enrollment
50
Registered
2017-07-02
Start date
2017-07-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney stone. Calculus of kidney

Interventions

Intervention 1: Intervention group: Tubeless intercostal percutaneous nephrolithotomy. Intervention 2: Control group: Standard intercostal percutaneous nephrolithotomy.
Treatment - Surgery
Treatment - Drugs
Intervention group: Tubeless intercostal percutaneous nephrolithotomy.
Control group: Standard intercostal percutaneous nephrolithotomy.

Sponsors

Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age of 18 to 65 years; stone with a diameter of more than 1 cm in the lower calyx; stone with a diameter of more than 2 cm in the upper and middle calyx and the pelvis; a stone with a diameter of more than 1 cm in the upper urethra. Exclusion criteria: A previous history of kidney surgery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Amount of analgesic usage. Timepoint: during 72 hours after surgery. Method of measurement: based on medical document.;Duration of hospitalization. Timepoint: after surgery upon discharge. Method of measurement: based on medical document.

Secondary

MeasureTime frame
Side effect of surgery (bleeding, damage to the kidney collecting system, spleen damage, colon damage, major vessel damage and pneumothorax). Timepoint: upon 72 hours after surgery. Method of measurement: through physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mahdi Shahmirzaei

Besat Hospital

msh1166@gmail.com+98 81 3364 0030

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026